ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2007;6:665-672. doi:10.1510/icvts.2007.160051
© 2007 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Antonios Kallikourdis
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kallikourdis, A.
Right arrow Articles by Jacob, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kallikourdis, A.
Right arrow Articles by Jacob, S.
Related Collections
Right arrow Education
Right arrow Valve disease

Best evidence topic - Valves

Is a stentless aortic valve superior to conventional bioprosthetic valves for aortic valve replacement?

Antonios Kallikourdis* and Samuel Jacob

Department of Cardio-thoracic Surgery, Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN, UK

*Corresponding author. Tel.: +44-7849729149; fax: +44-1224553506.

E-mail address: adonkal{at}doctors.org.uk (A. Kallikourdis).

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether a stentless valve is superior to conventional stented valves when tissue aortic valve replacement is performed. Altogether more than 515 papers were found using the reported search, of which 16 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude that stentless valves allow a larger effective orifice area valve to be implanted with a lower mean and peak aortic gradient postoperatively. At six months several studies and a meta-analysis have shown superior left ventricular mass regression in the stentless valve groups. However, by 12 months the stented valve groups catch up in terms of mass regression and this significance disappears. So the ‘eminent speaker from the floor’, was right with his statement, that there have been no definitively proven benefits for stentless valves.

Key Words: Stentless valve; Stented valve; Thoracic surgery; Aortic valve replacement







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 European Association for Cardio-thoracic Surgery